Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
May 16, 2022 at 03:44 pm EDT
Adimmune Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 52.8 million compared to TWD 6.93 million a year ago. Net loss was TWD 234.61 million compared to TWD 249.8 million a year ago. Basic loss per share from continuing operations was TWD 0.55 compared to TWD 0.58 a year ago. Diluted loss per share from continuing operations was TWD 0.55 compared to TWD 0.58 a year ago. Basic loss per share was TWD 0.55 compared to TWD 0.58 a year ago. Diluted loss per share was TWD 0.55 compared to TWD 0.58 a year ago.